Effect of a Strength Training Program on Blood Sugar Levels in Office Workers with Type 2 Diabetes Mellitus

Develop,Implement, and Evaluate of a Workplace-Based Resistance Training Intervention for Glycemic Control Among Office Workers with Type 2 Diabetes Mellitus. - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/092670

Enrollment

Registered

2025-08-08

Start date

Unknown

Completion date

Unknown

Last updated

2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Workplace-Based Resistance Training Four Months: The intervention will be developed through a two-round expert consensus process (Phase 1) to create a workplace-specific resistance trai

Eligibility

Inclusion criteria

Inclusion criteria: The study includes adults aged between 30 to 55 years who are full-time employees engaging in sedentary office work for at least five hours daily and have a diagnosis of Type 2 Diabetes Mellitus with controlled glycemic levels, specifically HbA1c between 6.5% to 7.5% and fasting blood glucose between 124 to 200 mg/dL. Both men and women working regular daytime hours in the office are eligible. The intervention group consists of staff from the Manipal Academy of Higher Education (MAHE), whereas the control group includes personnel from other similar workplace settings.

Exclusion criteria

Exclusion criteria: Exclusion criteria encompass individuals with medical or orthopedic conditions restricting the ability to perform resistance exercises, pregnant or lactating women, those with uncontrolled diabetes indicated by HbA1c above 7.5%, those on unstable job status intending to leave within four months, current participation in other structured resistance training programs, allergies to materials used in exercises (e.g., latex), and those with neurological or nephrological complications such as foot ulcers limiting physical activity.

Design outcomes

Primary

Measure	Time frame
Glycemic control measured by: 1. HbA1c percentage and mmol/mol 2. Fasting blood glucose (mg/dL)Timepoint: A. Baseline (pre-intervention) B. Mid-intervention (after 2 months) C. Post-intervention (after 4 months)	—

Secondary

Measure	Time frame
1. Blood pressure (millimeters of mercury) 2. Heart rate variability (milliseconds) 3. Upper limb strength (measured by Hand-held Dynamometer in Newtons) 4. Lower limb strength (measured by 30-second Chair Stand Test, number of repetitions) 5. Body composition parameters, including BMI (kg/m )Timepoint: A. Baseline (pre-intervention) B. Mid-intervention (after 2 months) C. Post-intervention (after 4 months)	—

Measure

Time frame

1. Blood pressure (millimeters of mercury) 2. Heart rate variability (milliseconds) 3. Upper limb strength (measured by Hand-held Dynamometer in Newtons) 4. Lower limb strength (measured by 30-second Chair Stand Test, number of repetitions) 5. Body composition parameters, including BMI (kg/m )Timepoint: A. Baseline (pre-intervention) B. Mid-intervention (after 2 months) C. Post-intervention (after 4 months)

—

Countries

India

Contacts

Public ContactEswaranTPM

Manipal College of Health Professions, Manipal Academy of Higher Education

tpmeswaran@gmail.com9655497363

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026